Phase I Trial of Radiotherapy Combined with Durvalumab Alone Plus Either Monalizumab or Oleclumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer NSCLC ARCHON-1

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03801902

Study #:
STUDY00144038

Start Date:
Aug 25, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03801902

View Complete Trial Details & Eligibility at ClinicalTrials.gov